Advertisement

Sigma-Aldrich introduced Precisio Kinases, a new collection of active kinases that is expected to enable scientists to achieve greater insight into protein phosphorylation and cell signaling. Optimized for high-throughput kinase screening and profiling, Precisio Kinases allow for the characterization of cellular processes and may contribute to new therapeutic strategies for treating diseases including cancer, diabetes, and hypertension. The kinases are suitable for high throughput screening and profiling. Each Precisio Kinase contains a batch-optimized assay protocol, ensuring high performance, quick implementation and consistent results in a variety of applications. Sigma-Aldrich, 800-325-3010, www.sigma.com/precisiokinases
Advertisement
Advertisement